GlobeNews Wire

ROCKET DOCTOR AI INC. ANNOUNCES AUTOMATIC CONVERSION OF SPECIAL WARRANTS

Vancouver, British Columbia, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (the “Company” or “Rocket Doctor AI”) (CSE:…

9 months ago

Constellation Software Inc. Announces Conference Call

September 26, 2025 17:03 ET  | Source: Constellation Software Inc. TORONTO, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc.…

9 months ago

24/7 Market News: Kraig Labs Offers Safer, Natural Alternative to Health Risks from Nylon and Polyester Clothing

DENVER, Sept. 26, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial…

9 months ago

Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025

September 26, 2025 New Rembra RT and Areta RT [1] CT platforms drive accuracy and efficiency in radiation therapy with…

9 months ago

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

September 26, 2025 09:30 ET  | Source: Orion Oyj ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS26 September 2025…

9 months ago

Reserve Bank of India approves biometric payment authentication technology

September 26, 2025 02:15 ET  | Source: IDEX BIOMETRICS ASA Reserve Bank of India (RBI) has approved biometric authentication technology…

9 months ago

Annature helps accounting firms and company directors manage corporate compliance fees with new product launch

BRISBANE, Australia, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Annature, Australia’s leading provider of digital signing and identity verification solutions, has…

9 months ago

ROG Xbox Ally and ROG Xbox Ally X Now Available for Pre-Order in Canada

KEY POINTS Order now: Pre-orders for ROG Xbox Ally X and ROG Xbox Ally start at 8:00 p.m. ET on…

9 months ago

Medicenna Announces Results of Annual Meeting of Shareholders

TORONTO and HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage…

9 months ago

Organogenesis Provides Update on Second Phase 3 ReNu Study

Company maintains confidence in ReNu as innovative pain management therapy Second Phase 3 trial demonstrates numerical improvement in baseline pain…

9 months ago